Clinical Application Guidelines for Blood-Based Circulating Tumor DNA Assays-Reference-Cited by-同舟云学术

Clinical Application Guidelines for Blood-Based Circulating Tumor DNA Assays

Published:2024-07-01 Issue:3 Volume:14 Page:176-190
ISSN:2093-6338
Container-title:Laboratory Medicine Online
language:en
Short-container-title:Lab Med Online

Author:

Lee Jee-Soo¹,Cho Eun Hye²,Kim Boram³,Hong Jinyoung⁴,Kim Young-gon³,Kim Yoonjung⁵,Jang Ja-Hyun³,Lee Seung-Tae⁵⁶,Kong Sun-Young⁷,Lee Woochang⁸,Shin Saeam⁵^ORCID,Song Eun Young¹^ORCID,

Affiliation:

1. Department of Laboratory Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea

2. Department of Laboratory Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea

3. Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

4. Samkwang Medical Laboratories, Yonsei University College of Medicine, Seoul, Korea

5. Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea

6. Dxome Co. Ltd., Seongnam, Korea

7. Department of Laboratory Medicine, National Cancer Center, Goyang, Korea

8. Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

Publisher

Laboratory Medicine Online

Link

https://pdf.medrang.co.kr/LMO/2024/014/LMO014-03-176.pdf

Reference91 articles.

1. Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review

2. Cost-Effectiveness Analysis of Three Diagnostic Strategies for the Detection of EGFR Mutation in Advanced Non-Small Cell Lung Cancer

3. Optimization of a Protocol for Isolating Cell-free DNA From Cerebrospinal Fluid

4. Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility

5. Circulating tumor-derived DNA is shorter than somatic DNA in plasma